Hochschulschrift
Targeting effectors of metabolic reprogramming in hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
iii, 123 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Medizinische Hochschule Hannover, Dissertation, 2021
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wann)
-
November 2020
- Urheber
- Beteiligte Personen und Organisationen
-
Balakrishnan, Asha
Ott, Michael
Morgan, Michael Alexander
Vondran, Florian
Medizinische Hochschule Hannover
Hannover Biomedical Research School
Klinik für Gastroenterologie, Hepatologie und Endokrinologie
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Olarewaju, Olaniyi
- Balakrishnan, Asha
- Ott, Michael
- Morgan, Michael Alexander
- Vondran, Florian
- Medizinische Hochschule Hannover
- Hannover Biomedical Research School
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie
Entstanden
- November 2020
Ähnliche Objekte (12)
An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Multidisciplinary treatment of hepatocellular carcinoma
Targeting FUBP1 in Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Computational Analysis of Metabolic Reprogramming in Tumors
An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Multidisciplinary treatment of hepatocellular carcinoma
Targeting FUBP1 in Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Computational Analysis of Metabolic Reprogramming in Tumors
An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Multidisciplinary treatment of hepatocellular carcinoma
Targeting FUBP1 in Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients